Transmission of West Nile Virus through blood transfusion in the United States in 2002.
Pealer LN, Marfin AA, Petersen LR, et al.
N Engl J Med 2003;349:1236-1245.
Review by
Transfusion risks of yesterday and of today. [Article in French]
Allain JP
Transfus Clin Biol 2003;10(1):1-5.
Review by
US NAT yield: where are we after 2 years?
Stramer SL
Transfus Clin Biol 2003;10(1):10-18.
Review by
The use of acute normovolemic hemodilution in patients undergoing cardiac surgery.
Jovic ME, Calija BM, Radomir BJ, et al.
Cardiovasc Surg 2003;11(3):201-205.
Review by
How effective is acute normovolaemic haemodilution in femoro-distal bypass surgery?
Spark JI, Chetter IC, Kester RC, Scott DJA
Cardiovasc Surg 2002;10(5):460-463.
Review by Van der Linden P
Recombinant human transgenic antithrombin in cardiac surgery: a dose-finding study.
Levy JH, Despotis GJ, Szlam F, Olson P, Meeker D, Weisinger A
Anesthesiology 2002;96(5):1095-1102.
Review by W. Dietrich
Effect of blood transfusion on long-term survival after cardiac operation.
Engoren MC, Habib RH, Zacharias A, Schwann TA, Riordan CJ, Durham SJ
Ann Thorac Surg 2002;74(4):1180-1186.
Review by Hardy JF
Transfusion-related alloimmune neutropenia: an undescribed complication of blood transfusion.
Wallis JP, Haynes S, Stark G, Green FA, Lucas GF, Chapman CE
Lancet 2002;360(9339):1073-1074.
Review by Kretschmer V
Reduction in erythropoietin doses by the use of chronic intravenous iron supplementation in iron-replete hemodialysis patients.
Chang CH, Chang CC, Chiang SS
Clin Nephrol 2002;57(2):136-141.
Review by Gasche C
Transfusion practices for elective orthopedic surgery.
Feagan BG, Wong CJ, Johnston WC, et al.
CMAJ 2002;166(3):310-314.
Review by
Coronary artery bypass grafting surgery without the routine application of blood products: is it feasible?
Wilhelmi M, Franke U, Cohnert T, et al.
Eur J Cardio Thorac Surg 2001;19(5):657-661.
Review by